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The Chk2-p53-PUMA pathway is a major regu-
lator of DNA-damage-induced apoptosis in re-
sponse to double-strand breaks in vivo.
Through analysis of 53BP1 complexes we
have discovered a new ubiquitin protease,
USP28, which regulates this pathway. Using
a human cell line that faithfully recapitulated
the Chk2-p53-PUMA pathway, we show that
USP28 is required to stabilize Chk2 and
53BP1 in response to DNA damage. In this cell
line, both USP28 and Chk2 are required for
DNA-damage-induced apoptosis, and they ac-
complish this in part through regulation of the
p53 induction of proapoptotic genes like
PUMA. Our studies implicate DNA-damage-in-
duced ubiquitination and deubiquitination as
a major regulator of the DNA-damage response
for Chk2, 53BP1, and a number of other pro-
teins in the DNA-damage checkpoint pathway,
including several mediators, such as Mdc1,
Claspin, and TopBP1.
INTRODUCTION
In response to DNA damage, phosphatidylinositol 3-ki-
nase (PI3K)-like kinases (PIKKs), such as ataxia-telangiec-
tasia-mutated (ATM), ataxia-telangiectasia, Rad3-related
(ATR) and DNA-dependent protein kinase (DNA-PKcs),
initiate a cascade of cellular events that modulate gene
transcription, cell-cycle progression, DNA repair, and ap-
optosis (Bakkenist and Kastan, 2004; Zhou and Elledge,
2000). In addition, cohorts of cellular factors are also in-
volved to transduce the signals initiated by ATM and
ATR to downstream checkpoint kinases, such as Chk1
and Chk2. There are two major groups of regulators for
the PIKKs: PIKK specificity factors and checkpoint medi-ators. PIKK specificity factors, such as the MRN complex
(Mre11, Rad50, and Nbs1) for ATM, ATRIP for ATR, and
Ku70/80 for DNA-PKcs, are thought to recruit PIKKs to
particular forms of damaged DNA and regulate their activ-
ities (Cortez et al., 2001; Falck et al., 2005). The check-
point mediators, such as 53BP1, Mdc1, TopBP1, Claspin,
and BRCA1, have been proposed to function in part as
scaffolds to bring together the PIKKs and their substrates
(Bakkenist and Kastan, 2004; Zhou and Elledge, 2000).
Together, they act on checkpoint kinases Chk1 and
Chk2, transcription factors such as p53, repair proteins,
and other factors to promote either rescue from damage
or commitment to apoptosis.
Responses to ionizing irradiation (IR) are of great inter-
est both because IR is mutagenic and contributes to the
genesis of cancer and because IR is used therapeutically
to kill cancer cells, often by apoptosis. Primarily from stud-
ies in mice, it is clear that the sensitivity to IR-induced ap-
optosis is highly tissue and cell-type specific. DNA-dam-
age response proteins implicated in IR-induced
apoptosis include ATM (developing brain) (Herzog et al.,
1998), DNA-PKcs (thymocytes) (Wang et al., 2000), Chk2
(thymocytes, developing brain, epidermis, and hair folli-
cles) (Hirao et al., 2002; Takai et al., 2002), and most im-
portantly p53 (thymocytes, cerebellum, spleen, small
bowel, epithelial cells from tongue, and small intestine)
(Clarke et al., 1993; Fei et al., 2002; Lowe et al., 1993). Re-
cently, a direct transcriptional target of p53 called PUMA
(p53 upregulated modulator of apoptosis), has been
shown to recapitulate most, if not all, of the apoptotic de-
fective phenotypes seen in p53 null mice (Jeffers et al.,
2003; Villunger et al., 2003). PUMA is a BH3-only (Bcl-2
homology 3) protein that plays an essential role in apopto-
sis initiation (Danial and Korsmeyer, 2004). Thus, PUMA
may be the primary liaison between p53 and initiation of
apoptosis in response to ionizing irradiation.
Among the DNA-damage response proteins, check-
point mediators, such as 53BP1, Mdc1, and Claspin, are
of critical importance in responding to IR and transducing
signals to the checkpoint kinases (Wang et al., 2002;WardCell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc. 529
et al., 2003). They are human orthologs of Rad9 and Mrc1
in S. cerevisiae and Crb2/Rhp9 and Mrc1 in S. pombe
(Alcasabas et al., 2001; Sun et al., 1998; Sweeney et al.,
2005; Tanaka and Russell, 2001; Vialard et al., 1998).
While it appears that phosphorylation is likely to be impor-
tant for activating these mediators for signal transduction,
how they are turned off is still unknown. To better under-
stand how cells respond to DNA damage, we searched
for new factors involved in the DNA-damage response
by purifying 53BP1 complexes. A prominent binding pro-
tein was identified as ubiquitin specific protease 28
(USP28). We show that USP28 plays a critical role in pro-
motion of the Chk2-p53-PUMA-signaling pathway and
together with Chk2 protects the stabilities of key DNA-
damage-signaling factors in response to DNA damage.
RESULTS
In order to identify new factors involved in the DNA-dam-
age response, we performed tandem affinity purification
(TAP) using C-terminal TAP-tagged full-length 53BP1
(53BP1-TAP) as the bait. After Commassie blue staining,
one prominent band migrating around 140 kDa was iden-
tified by mass spectrometry (MALDI-TOF) as USP28
(Figure 1A). USP28 belongs to a family of enzymes, called
deubiquitinating enzymes (DUBs), which remove ubiquitin
from the ubiquitin conjugates (Amerik and Hochstrasser,
2004). Among five classes of DUBs identified, two major
classes of DUBs have been studied extensively: the
UCHs (ubiquitin carboxy-terminal hydrolases) and the
UBPs (ubiquitin processing enzymes). UCH family mem-
bers are usually small in size (20–30 kDa), whereas
UBPs are much larger (60–300 kDa). While the UCH pro-
teins are highly conserved, other than the two conserved
regions around the catalytic cysteine (Cys box, also called
UCH-1, approximately 19 amino acids) and histidine (His
box, also called UCH-2, between 60 and 90 amino acids),
the UBPs are quite diverse. USP28 belongs to the UBP
family and its closest paralog is USP25 with which it
shares 84% amino acid identity (Figure 1B) (Valero et al.,
2001). The biological functions of USP28 and USP25
have not been previously described. In order to study
the function of USP28 in the DNA-damage response, we
raised antibodies against amino acids 1–332 of USP28.
Using this antibody we examined the association of en-
dogenous USP28 and 53BP1 (Figure 1C). Approximately
5%–10% of 53BP1 can be coimmunoprecipitated with
USP28.We verified the binding and specificity of the inter-
actions between USP28 and 53BP1 by transiently ex-
pressing HA-USP28, HA-USP25, or HA-USP7 in 293T
cells. As shown in Figures 1D and 1E, 53BP1 specifically
interacts with USP28 but not USP25 or USP7. DNA dam-
age did not dramatically change the interaction between
USP28 and 53BP1 (Figure 1F). 53BP1 has been shown
to function in regulation of the Chk2-p53 pathway and im-
munoglobulin heavy chain class-switch recombination in
mouse B cells (Manis et al., 2004; Wang et al., 2002;
Ward et al., 2003, 2004). The roles of Chk2 in p53 regula-530 Cell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc.tion are highly cell-type specific (Hirao et al., 2002; Takai
et al., 2002). It has been difficult to recapitulate the pheno-
types of the Chk2 knockout mouse with respect to p53
regulation in human cell lines probably because this path-
way is deregulated in many tumors (Ahn et al., 2003; Jal-
lepalli et al., 2003). To study the physiological role of
USP28 in response to DNA damage, we wished to employ
a human cell line that is able to recapitulate the pheno-
types previously observed in knockout mice of known
DNA-damage response genes, such as Chk2, p53, and
PUMA. We examined a number of cell lines and focused
on the lung carcinoma cell line H460, which has wild-
type p53 and has been widely used to study pathways in-
volving p53.We first examined the induction of p53 and its
bona fide target PUMA in response to ionizing irradiation.
We treated cultured H460 cells with 10 Gy of IR. At differ-
ent times, cells were collected and the levels of p53 and
PUMA were examined (Figure 2A). In response to IR,
p53 was stabilized and its protein level peaks around 2–
4 hr. With the increasing level of p53, PUMA was induced
by 4 hr and its protein levels peak around 12–24 hr. Since
IR-induced apoptosis in mice is primarily p53 dependent,
we examined if the IR-induced apoptosis in H460 cells is
also p53 dependent. Several p53 mutants have been
shown to possess dominant-negative properties (Aurelio
et al., 2000; Rowan et al., 1996). We tested two such mu-
tants, p53-R248W and p53-R175P, and found them to re-
duce IR-induced apoptosis in H460 cells (Figures 2C and
S1). In addition, since Chk2 null mice show reduced p53
protein in response to IR and are also resistant to IR-
induced and p53-dependent apoptosis in certain cell
types (Hirao et al., 2000, 2002; Takai et al., 2002), we ex-
amined apoptotic phenotypes in H460 cells when Chk2
was inactivated either by siRNA knockdown or expression
of kinase-dead Chk2 (Chk2KD). The siRNA knockdown
efficiency for Chk2 is shown in Figure 5A. As shown in Fig-
ures 2B and 2C, inactivation of Chk2 also renders H460
cells resistant to IR-induced apoptosis. Thus our data
show that H460 cells faithfully reproduce many of the
physiologically relevant properties of the genes in the
Chk2-p53-PUMA pathway, including damage-induced
stabilization of p53, induction of PUMA, and p53- and
Chk2-dependent apoptosis.
Having established a physiologically relevant cellular
model system that recapitulates the Chk2-p53-PUMA
pathway, we next examined the consequences of
USP28 inactivation by siRNA or expression of a cata-
lytic-inactive version of USP28, USP28CI, in which the cat-
alytic cysteine was changed to alanine, C171A (Figure 3).
The siRNA knockdown efficiency for USP28 is shown in
Figure 4A. Similar to Chk2, loss of USP28 in H460 cells
also renders cells resistant to both IR-induced killing, as
analyzed by a colony formation assay (Figure 3A), and
IR-induced apoptosis, measured by a sub-G1 DNA
content assay (Figures 3B and 3C). Moreover, a catalytic
inactive mutant of USP25 had no obvious effects on
IR-induced apoptosis (Figure 3C), suggesting that the
apoptotic phenotype seen with USP28 is specific.
Figure 1. Identification of USP28 as a 53BP1-Interacting Protein
(A) C-terminal TAP-tagged 53BP1 (53BP1-TAP) was transfected into HeLa cells, and a clone stably expressing 53BP1-TAP was used for TAP puri-
fication. At the same time, a clone expressing TAP tag only was used as a negative control. Coomassie blue-stained 53BP1-associated proteins were
identified by mass spectrometry (MALDI-TOF). Arrows indicate proteins corresponding to 53BP1 and USP28, respectively.
(B) USP28 has four known domains identified by SMART: UCH-1 (Cys box, amino acids 162–196) and UCH-2 (His box, amino acids 580–649), ubiq-
uitin-interacting motif (UIM, 97–116), and coil-coiled domain (CC, amino acids 400–432).
(C) Coimmunoprecipitation was performed with control rabbit IgG, antibody against 53BP1 or USP28; WCL represents 10% of input. The immuno-
blotting antibodies (IB) are indicated on the right.
(D and E) WCLs from 293T cells transiently transfected either with HA-USP28, HA-USP25, or HA-USP7 were used for coimmunoprecipitation. Rabbit
or mouse IgG were used as negative controls. The blotting antibodies are indicated on the right. WCL represents 2% of input.
(F) Cells stably expressing HA-USP28 were either untreated () or treated with 1 mM hydroxy urea (HU) for 24 hr, 50 J/m2 UV, 10 Gy IR. The IR- and
UV-treated cells were harvested 1 hr later. HA: mouse monoclonal antibody against HA peptide. WCL represents 2% of input.Since USP28 is a 53BP1-interacting protein and a puta-
tive deubiquitinating enzyme, we examined the effects of
loss of USP28 function on 53BP1 protein levels. The re-duction of USP28 caused a slight reduction in 53BP1
levels in the absence of DNA damage (Figure 4A). Thirty
minutes after IR, 53BP1 levels increased slightly andCell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc. 531
Figure 2. Characterization of Human Lung Carcinoma Cell Line H460 in Response to Ionizing Irradiation
(A) Cells were either untreated () or treated with 10 Gy IR, then collected at the indicated times. Cell pellets were lysed in sample buffer and
sonicated. Equal amounts of lysate were run on an SDS-PAGE and blotted with antibodies against PUMA or p53 (DO-1).
(B andC) Chk2was inactivated either with siRNA (B) or by expression of kinase-deadChk2 from a retrovirus (Chk2-KD) (C). Cells infectedwith p53-DN
(R248W) expressing retrovirus were either untreated (0 hr) or treated with 10Gy of IR and collected 48 hr later. Apoptotic cells were analyzed by a sub-
G1 DNA content assay. Error bars represent the standard deviation.then rapidly disappeared by 1 hr post IR. Analysis of Chk2
protein revealed that, like 53BP1, in response to IR Chk2
levels become significantly reduced in the absence of
USP28 or in the presence of a dominant-negative catalyt-
ically defective allele (Figures 4B and 4C). These pheno-
types are specific to USP28 since siRNAs to USP25
have no such effects (Figure S2). The reduction of
53BP1 and Chk2 amounts in the absence of USP28 are
dependent on the 26S proteosome since treatment with
the proteosome inhibitor ALLN prevented their reduction
in response to IR (Figure 4E).
Unexpectedly, interference with USP28 function led to
the generation of a faster-migrating form of p53 in IR-
treated cells (marked by arrows in Figures 4B, 4C, and
4D). To map the alteration causing the faster-migrating
form of p53, we took advantage of well-characterized
antibodies that recognize different regions of p53
(Figure 4D). Full-length human p53 has 393 amino acids,
and only the antibody that recognizes the C-terminal
amino acids 375–393 of p53 failed to detect the faster-mi-
grating form. This suggests that the faster-migrating form
might represent a C-terminal truncated form of p53. This
hypothesis is consistent with the fact that the appearance
of the faster-migrating form is dependent on the 26S pro-
teosome, as treatment with proteosome inhibitors pre-532 Cell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc.vents its accumulation (Figure 4E). However, we do not
yet know the exact cleavage site, and we cannot rule
out the possibility that the altered mobility of p53 might re-
sult from a modification of the C terminus that also blocks
antibody recognition.
USP28 loss affects three components of the p53 signal-
ing pathway: 53BP1, Chk2, and p53 itself. To gauge the
consequences of USP28 loss on this pathway, we exam-
ined the p53-dependent induction of PUMA by IR (Figures
4F and 4G). Induction of PUMA by IR was severely com-
promised in the absence of USP28. Which of these
changes, alone or together, is responsible for the attenu-
ation of PUMA induction is not clear. However, we would
like to note that there is a previous link between the C ter-
minus of p53, which we observed to be altered under
these conditions, and the promotion of p53’s apoptotic
function. The C-terminal tail of human p53 contains
a stretch of highly basic residues (from amino acids
370–393), which are completely conserved in mice and
rats. Previously, truncation of this basic domain of p53
has been shown to primarily interfere with its apoptotic
functions but not its cell-cycle arrest functions (Almog
et al., 2000; Chen et al., 1996). An apoptotic function of
the C terminus of p53 is fully consistent with our observa-
tions since, when treated with IR, these cells induce
normal levels of p21 and arrest robustly at G1 and G2
phases of the cell cycle (Figure S4 and data not shown).
Thus, we feel this alteration of p53 might be the molecular
mechanism responsible for the apoptotic resistance phe-
notypes observed in USP28 compromised cells (Figure 3).
However, we cannot rule out the possibility that other
factors altered due to USP28 loss, such as altered modifi-
cation of p53 due to loss of Chk2, also affect its ability to
activate PUMA independent of cleavage.
Figure 3. Loss of USP28 in H460 Cells Causes Resistance to
IR-Induced Apoptosis
(A) Cells were transfected with siRNA either against GFP (control) or
USP28. Cells were untreated (0 hr) or treated with different doses of
IR, then plated at low density. Colonies were counted after 10 days
to determine viability and the percentage of surviving cells were plot-
ted against IR dose.
(B and C) USP28 were inactivated either by transfecting with siRNA (B)
or infecting with retroviruses expressing catalytic-inactive USP28
(C171A, USP28-CI) or USP25 (C178A, USP25-CI) mutants (C). Cells
were either untreated (0 hr) or treated with 10 Gy of IR. Apoptotic cells
were analyzed by the sub-G1 assay. Error bars represent the standard
deviation.To determine whether the effects of USP28 on 53BP1,
Chk2, and p53 were independent or potentially repre-
sented a pathway of dependent events, we examined
the effects of Chk2 loss in H460 cells. Surprisingly, when
Chk2 levels were reduced by siRNA knockdown, 53BP1
levels dropped. Treatment with IR transiently increased
53BP1 levels within 30 min, then 53BP1 levels precipi-
tously fell relative to control cells (Figure 5A). The reduc-
tion of 53BP1 continued up to 4 hr after IR (Figure 5B).
To demonstrate that the effects were due to loss of
Chk2 function, we generated H460 cells expressing
a dominant-negative, catalytically inactive Chk2 mutant,
Chk2KD, which also reduced 53BP1 levels in the absence
of exogenous DNA damage (Figure 5C). In the presence of
IR, both the siRNA-treated cells and Chk2KD cells pro-
duced the faster mobility form of p53 (marked by arrows
in both Figures 5B and 5C). One difference between the
siRNA-treated and Chk2KD cells was that the siRNA-
treated cells had high p53 levels in the absence of IR.
We take this to mean that these cells might be experienc-
ing some form of DNA damage. We do not know if these
differences are due to differences in the residual activity
of the Chk2 in these cells or additional effects due to the
treatment. siRNAs to unrelated proteins have been shown
to provided a nonspecific induction of p53 in some cases
(Scacheri et al., 2004).
To further support these observations and demonstrate
that other cell types have a similar relationship between
Chk2 and 53BP1, we examined 53BP1 protein levels in
B cells isolated either from wild-type or congenic Chk2
null mice. Like H460 cells, mouse cells lacking Chk2 also
showed a reduction in 53BP1 levels that was further exac-
erbated in response to IR (Figure 5G). However, the faster-
migrating form of p53 was not observed in these cells
(data not shown).
Both the reduction of 53BP1 and the appearance of the
high-mobility form of p53 are dependent on the normal
function of 26S proteosome in the absence of Chk2 func-
tion (Figure 5F), further recapitulating key parts of the
USP28 mutant phenotype. Consistent with the effects
on p53 mobility, the induction of PUMA is compromised
in the absence of Chk2 function (Figures 5D and 5E).
These observations indicate that Chk2 stabilizes 53BP1
in the absence and presence of DNA damage. Chk2 also
prevents the alteration of p53, thus promoting its apopto-
tic activity. The absence of Chk2 appears to cause a more
severe phenotype than loss of USP28.
The function of a DUB in the DNA-damage response in-
dicates a role for ubiquitination and proteolysis in the
DNA-damage-response pathway, perhaps as a mecha-
nism to tune down the system after signaling is initiated.
Given this possibility, we hypothesized that this protection
by USP28 might extend beyond 53BP1 and Chk2 to other
components of the signaling machinery. We therefore
surveyed a large number of proteins in the DNA-damage-
response pathway. Of these we found that ATR (Figures 4
and 5), ATM, Rad50, DNA-PK, Ku80, and Smc1 were
not affected (Figure S3). However, several key signalCell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc. 533
Figure 4. Inactivation of USP28 Leads to Reduction of Checkpoint Proteins in Response to IR and Attenuation of PUMA Induction
(A) H460 cells were transfected with either control siRNA or siRNA against USP28, then either untreated (IR) or treated with 10 Gy IR and collected at
the indicated times and probed with the indicated antibodies.
(B) H460 cells were treated as in (A) except transfected with two different control siRNAs and two different siRNAs against USP28 and collected 4 hr
after IR.
(C) H460 cells were infected either with vector or catalytic-inactive USP28 (USP28CI), then either untreated (IR) or treated with 10 Gy IR (+IR) and
collected 1 hr later. Whole-cell lysates were run on a 4%–12% SDS-PAGE and blotted with different antibodies, as indicated on the right. An arrow-
head marks a faster-migrating band recognized by DO-1.
(D) WCLs from (B) were run on a 4%–12%SDS-PAGE and blotted with antibodies that recognize different regions of p53. Arrows mark the position of
the faster-migrating form of p53.
(E) H460 cells were transfected with siRNA as in (A). Cells were then either untreated (IR) or treated with 10 Gy IR (+IR). Four hours later, cells were
treated with 20 mM of ALLN (+) for 4 hr.
(F and G) Cells treated as in (A) and collected at different times. Whole-cell lysates were run on 4%–20% SDS-PAGE and blotted with different an-
tibodies, as indicated on the right.transducers, including three checkpoint mediators, Clas-
pin, TopBP1, andMdc1, and two PIKK specificity determi-
nants, Nbs1 and ATRIP, showed significant reductions in
levels after IR in the absence of USP28 function (Figures534 Cell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc.6A and 6B). They also behaved like 53BP1 when Chk2
was impaired, showing a reduction even in the absence
of IR (Figures 6C and 6D). For Nbs1 and ATRIP, levels
were further reduced in Chk2KD-expressing cells after IR
Figure 5. Effects of Chk2 Loss on 53BP1, p53, and PUMA in Response to DNA Damage
(A) H460 cell were transfectedwith either control siRNA or siRNA against Chk2, then either untreated (IR) or treatedwith 10Gy IR and collected at the
indicated times.
(B) H460 cell were treated as in (A) and collected 4 hr after IR.
(C) H460 cells were infected either with vector or kinase-dead Chk2 (Chk2KD) then either untreated (IR) or treated with 10 Gy IR (+IR) and collected 1
hr later. Whole-cell lysates were run on a 4%–12% SDS-PAGE and blotted with different antibodies, as indicated on the right. The faster-migrating
band recognized by DO-1 is marked by an arrowhead.
(D and E) Cells were treated as in (A) and (C) and collected at different times. Whole-cell lysates were run on a 4%–20% SDS-PAGE and blotted with
different antibodies, as indicated on the right.
(F) H460 cells were transfected with siRNA as in (A). Cells were then either untreated (IR) or treated with 10 Gy IR (+IR). Four hours later, cells were
treated with 20 mM of ALLN (+) for 4 hr.
(G) B cells from wild-type (+/+) or Chk2 null mice (/) were treated with 10 Gy IR and collected at indicated times. Immunoblotting antibodies are
indicated on the right.(Figure 6D). As observed for 53BP1, the reduction in levels
of theseproteins is alsodependent on the26Sproteosome
(Figure S5). Intriguingly, the proteinswhose stabilities have
been affected are themselves substrates of ATM and ATR.In addition, with the exception of ATRIP and Claspin, each
also have phospho-amino acid interaction domains, such
as FHA or BRCT domains, while none of the proteins
whose levels were not affected have these domains.Cell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc. 535
536 Cell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc.
The simplest model for how USP28 protects the levels
of these proteins would be through USP28-mediated deu-
biquitination. This would predict a physical association.
Thus we examined an association of several of these pro-
teins with USP28. We were able to immunoprecipitate
Claspin and Mdc1 with antibody against USP28 (Fig-
ure 6E). Thus, USP28 physically associates with three of
the proteins it regulates: 53BP1, Claspin, and Mdc1.
The physical association of USP28 with these proteins
implies that reduction of levels of these proteins in the
absence of a protective DUB is due to a reduction in their
stability, as opposed to a change in the rate of translation,
for example. To examine the stability of some of theseme-
diators directly, we measured the half lives of representa-
tive proteins 53BP1 and Claspin in either control siRNA-
treated cells or in cells treated with siRNA against USP28.
In cells treated with control siRNAs, 53BP1 becomes
slightly less stable when treated with IR (Figures 7A and
7B). In cells treated with siRNA to USP28 showed a reduc-
tion in the basal stability of 53BP1 in the absence of IR,
which is consistent with the slight reduction of 53BP1
levels in USP28 siRNA-treated cells observed in Figure 4A,
and even greater instability in the presence of IR (Figures
7A and 7B). Claspin showed a similar dependency on
USP28 for stability. In control cells,Claspin showedaslight
stabilization in the presence of IR (Figures 7A and 7C),
consistent with its increase in abundance in IR-treated
cells (Figures 6A–6D). However, in the absence of
USP28, Claspin became very unstable and this instability
made it difficult to measure the effect of IR (Figures 7A
and 7C).
It is an open question whether USP28 is an effector of
the ATM pathway or whether it acts constitutively. The
fact that USP28 controls the stability of 53BP1 and Clas-
pin in the absence of IR treatment suggests that USP28
has some basal activity but could still be regulated in re-
sponse to DNA damage. If USP28 were an effector of
the ATM pathway, we might expect it to be phosphory-
lated. Therefore, we immunoprecipitaed endogenous
USP28 after IR treatment and analyzed its phosphoryla-
tion status by tandem mass spectrometry (MS-MS). We
found that three serine residues of USP28 were specifi-
cally phosphorylated in response to IR, and two of these,
serine 67 and serine 714, are SQ sites, which are potential
ATM/ATR phosphorylation sites. We raised antibodies
against the phosphoserine 67 and phosphoserine 714
and used them to confirm that endogenous USP28 is
phosphorylated in response to IR (Figure 7D). Moreover,
these phosphorylation events are dramatically reduced
in ATM null cells (Figure 7E), indicating that the IR-induced
phosphorylation on serine 67 and serine 714 of USP28 are
ATM dependent and that USP28 is an effector in the ATMpathway. Furthermore, there appears to be a basal level
of USP28 phosphorylation even in the absence of IR
treatment for Ser67, suggesting the presence of some
constitutive ATM signaling, which could contribute to the
basal function of USP28.
To formally demonstrate that USP28 is a deubiquitinat-
ing enzyme, we purified both wild-type and catalytic-
inactive USP28 from 293T cells. As shown in Figure 7F,
wild-type but not the catalytic-inactive USP28 robustly
deubiquitinated tetraubiquitin in vitro, indicating that
USP28 is indeed a bona fide DUB.
Next, we examined if indeed these checkpoint proteins
are polyubiquitinated in vivo. We focused on Claspin be-
cause it exhibited the strongest dependency on USP28
for stability.We immunoprecipitated endogenousClaspin,
then blotted with an antibody that specifically recognizes
polyubiquitin chains. When proteosomes were inhibited
by ALLN, Claspin and its polyubiquitinated forms in-
creased dramatically (Figure 7G). Consistent with our hy-
pothesis that USP28 stabilizes Claspin, we observed
more polyubiquitinated Claspin in the absence of USP28
(Figure 7H). Moreover, USP28 deubiquitinated polyubiqui-
tinated Claspin in vitro, suggesting that Claspin is likely
a potential physiological substrate of USP28 (Figure 7I).
Taken together, the physical association and stability
regulation results suggests that in response to DNA dam-
age USP28 plays a critical role in stabilizing the specificity
factors and mediators of ATM and ATR signaling, thereby
allowing cells either to repair damaged DNA or to undergo
apoptosis.
DISCUSSION
Ubiquitin has been implicated in a limited manner in DNA
repair, as PCNA and FANCD2 are monoubiquitinated in
response to DNA damage (Garcia-Higuera et al., 2001;
Kannouche et al., 2004). Furthermore, Cdc25A is known
to be degraded in response to DNA damage through the
SCF pathway to control cell-cycle arrest (Busino et al.,
2003; Jin et al., 2003). Chk1 has also been shown to be
turned over via ubiquitin-mediated proteolysis after acti-
vation (Zhong et al., 2005). Furthermore, a key signal
transduction protein, BRCA1, has ubiquitin-ligase activity
although its substrate is not known (Ruffner et al., 2001).
Through the analysis of the lung carcinoma line H460
and mouse B cells we have shown that ubiquitination
and deubiquitination play much wider-ranging roles in
the DNA-damage response than previously appreciated.
The discovery of a physiologically intact cell-culturemodel
system has been critical to this analysis. H460 cells faith-
fully recapitulate the IR-induced and p53-dependentFigure 6. USP28 and Chk2 Control the Abundance of Several DNA-Damage Response Proteins in H460 Cells
(A–D) USP28 and Chk2 help to stabilize a cohort of checkpoint proteins. WCLs from either Figures 4B and 4C or Figures 5B and 5C were blotted with
antibodies against different checkpoint proteins, as indicated on the right.
(E) WCLs from either untreated () or 10 Gy IR-treated (+) cells were used for immunoprecipitation with antibody against USP28. Ten percent WCL
was used as abundance controls. C: control rabbit IgG.Cell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc. 537
Figure 7. USP28 Is a Ubiquitin Protease that Controls the Stabilities of 53BP1 and Claspin in H460 Cells
(A) Half-life determination of 53BP1 and Claspin. H460 cells were transfected with either control siRNA or siRNA against USP28. For +IR samples,
cells were treated with 10 Gy of ionizing irradiation. Cells were incubated at 37C for 30 min, and then 40 mg/ml of cyclohexamide (CHX) was added.
At different times after addition of CHX, cells were collected and equal amounts of WCLs were immunoblotted with different antibodies indicated on
the right.
(B and C) Quantitation of 53BP1 (B) and Claspin (C) proteins from (A) normalized against the protein levels of actin.
(D) 293T cells were either untreated () or treated (+) with 10 Gy IR and collected 1 hr after IR. WCLswere used for immunoprecipitation (IP) either with
an antibody raised against phosphoserine 67 of USP28 (pS67) or against phosphoserine 714 of USP28 (pS714).
(E) ATM wild-type or null cells were treated with 10 Gy IR and collected 1 hr after IR. WCLs were used for immunoprecipitation either with pS67 or
pS714. (F) FLAG-tagged USP28-WT or USP28-CI proteins were purified from 293T cells. Twomicroliters of purified proteins (100 ng) were run on an
SDS-PAGE gel and stained with silver staining (top panel). BSA was used as a protein standard. In vitro deubiquitination assays were performed at
37C for the indicated times and samples were run on a 4%–20% SDS-PAGE. The gel was blotted with antibody against ubiquitin (bottom panel).
Tetra-, tri-, di-, and monoubiquitin are indicated on the right.
(G) H460 cells were either mock-treated (ALLN) or treated with 20 mM of ALLN for 4 hr (+ALLN). Whole-cell extracts were used for immunoprecip-
itation. Rabbit IgG was used as negative control.
(H) H460 cell were transfected either with control siRNA or siRNA against USP28. Cells were treated with 10 Gy IR and incubated at 37C for 4 hr.
Immunoprecipitation was done as in (G).
(I) Equal amount of immunoprecipitated Claspin from H460 cells were either mock treated or treated with USP28-WT from (F) in DUB buffer for 0, 4,
and 6 hr at 37C. The reaction was stopped by addition of 23 sample buffer and samples were run on a 4%–12%SDS-PAGE. The gel was blottedwith
antibody against polyubiquitin.apoptotic phenotypes seen in Chk2, p53, and PUMA
knockout mice, which have not been previously demon-
strated in any human cell lines. This has provided a physi-
ologically accurate system in which to study themolecular
mechanism controlling ionizing irradiation-induced Chk2-
p53-PUMA-dependent apoptosis, something that has not
been possible outside of the context of the whole animal.538 Cell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc.Using this system, we showed that loss of a 53BP1-as-
sociated deubiquitinating enzyme, USP28, renders cells
resistant to IR-induced apoptosis, similar to what has
been seen with Chk2, p53, and PUMA null mice. H460
cells were critical for this analysis because several lines,
including HeLa and U-2 OS cells, do not respond to
USP28 and Chk2 loss like H460 cells (data not shown).
USP28 Controls the Abundance of Multiple
DNA-Damage-Signaling Proteins
In the absence of USP28, three groups of checkpoint pro-
teins become unstable in response to ionizing irradiation.
They are checkpoint mediators (53BP1, Mdc1, TopBP1,
and Claspin), PIKK specificity factors (Nbs1 and ATRIP),
and a checkpoint kinase (Chk2). These events lead to
the attenuation of DNA-damage signals and inactivation
of p53’s apoptotic function. The catalytic activity of
USP28 is required for this activity, as a dominant-negative
version containing a mutation in the catalytic cysteine
phenocopies the siRNA depletion of USP28.
Chk2 Functions in the USP28 Pathway
We found these checkpoint proteins also failed to be stabi-
lized in the absence of Chk2 function. Curiously, removing
Chk2 caused a reduction even in nondamaged cells. Most
importantly, these observations were also seen in B cells
isolated from Chk2 null mice. USP28 and Chk2 control
the same groups of proteins, and they are clearly acting
in the same pathway. Chk2 is protected by USP28 func-
tion; thus, it is formally downstream of USP28. However,
it has a more severe phenotype in the absence of DNA
damage than USP28. This could be explained if Chk2
was both upstream and downstream of USP28, and in
the absence ofChk2 spontaneousDNAdamage occurred.
This would then be the equivalent of a USP28 mutant
treated with DNA damage. Support for this hypothesis
comes from the fact that the basal levels of p53 are high
in cells transfected with siRNA to Chk2. Basal p53 levels
are not increased in cells expressing a catalytically defec-
tive Chk2 mutant, although many of the same proteins
are reduced in the absence of damage. However, the
establishment of a viable cell line might select for minimal
damage and low constitutive p53 levels and thus could still
be generating some constitutive damage.
The notion that Chk2 might control the function of
USP28 or the substrates it recognizes is attractive be-
cause the simplest explanation of USP28’s function is to
directly deubiquitinate the proteins that are destroyed in
its absence in response to IR. Since USP28 appears to
be in complexes with three of its potential substrates,
53BP1, Mdc1, and Claspin, it is likely to directly regulate
these proteins to control their stabilities. Unfortunately,
we were unable to test this directly for 53BP1 because
we could not detect ubiquitinated 53BP1. However, the
highly polyubiquitinated forms of Claspin were increased
in the absence of USP28, thus increasing the likelihood
that others are also direct targets. Furthermore, USP28
protein can act to reduce Claspin-ubiquitin conjugates
in vitro, arguing for a direct enzymatic role.
Regulation of p53 by USP28 and Chk2
The block to apoptosis observed in the absence of USP28
and Chk2 is likely to be explained in part by the appear-
ance of an altered form of p53 that has increased mobility
in irradiated cells when either the levels or activities of
USP28 or Chk2 are reduced. This alteration is consistentwith aC-terminal truncation of the basic domain of p53, al-
though we cannot rule out other modifications. It has been
shown that p53’s cell cycle and apoptotic functions can
be genetically separated (Almog et al., 2000; Aurelio
et al., 2000; Chen et al., 1996; Rowan et al., 1996). The de-
letion of the C-terminal basic domain of p53 affects only its
apoptotic function, and this is consistent with what we ob-
served for p53 function in the absence of USP28 and
Chk2. Recently, the basic domain has been proposed to
contribute to the linear diffusion of p53 along DNA (McKin-
ney et al., 2004). Thus, protecting the C-terminal basic
domain of p53maybecritical for its function as a transcrip-
tion factor. It is not clear whether the generation of a
high-mobility form of p53 represents a normal inter-
mediate in the proteolysis pathway of p53 or whether it
is a form that is generated under circumstances where
cells might wish to arrest the cell cycle without undergoing
apoptosis. If the mobility change is due to partial proteol-
ysis the identification of the protease will be important in
understanding p53 function. One candidate is the proteo-
some itself because blocking proteosome activity pre-
vents accumulation of the high-mobility form of p53. The
process through which the proteosome destroys ubiquiti-
nated proteins versus performing a proteolytic cleavage at
a defined site such as that in the Cubitus interruptus
(Jiang, 2002) protein is not understood. It will be important
to understand the role of Chk2 and USP28 in the protec-
tion of p53.
Dynamic Roles for Ubiquitination
in the DNA-Damage Response
What is the physiological role of USP28 in the DNA-dam-
age response? To gain perspective on this question, it is
important to realize that USP28 acts in several pathways
that can have opposing functions. For example, it regu-
lates Claspin, which is phosphorylated in response to IR
and is required for IR resistance (Lin et al., 2004). In addi-
tion, it regulates the Chk2-p53 pathway, which controls
apoptotic death. Thus USP28’s effects on survival are
likely to be a mixture of death-protecting and -promoting
effects whose balance in H460 cells results in increased
survival. Because of the complexity of the response, the
physiological effects due to the regulation of any individual
protein are difficult to isolate. These complexities aside,
USP28 clearly acts to promote signaling in the response
to ionizing radiation. It functions to promote the ATM-
53BP1-Chk2-p53-PUMA pathway, and it is a direct sub-
strate of ATM itself and is therefore likely to be regulated
in response to DNA damage.
USP28 seems to exist in a balance with opposing E3
activities that appear to be activated in response to DNA
damage. One revealing piece of information has been
the behavior of 53BP1 in the absence of Chk2. Initially
its levels are quite low, but in response to IR, its levels
transiently rise and then drop again. This may indicate
that the initial response to DNA damage is to increase
the stability of some of the DNA-damage components
right away to facilitate signaling. We have also observedCell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc. 539
a USP28-dependent stabilization of Claspin in wild-type
(wt) cells in response to IR. The initial stabilization of
53BP1 and other proteins in response to DNA damage
could be due to inhibition of an E3 or activation of a differ-
ent DUB. The identities of the E3s in this pathway are not
yet known, although BRCA1 and Mule are possibilities
(Chen et al., 2005; Ruffner et al., 2001; Zhong et al.,
2005). If the balance of these opposing pathways changes
over time, such as to inactivate USP28 after the damage
signal is reduced, it could act to shut off the response to
return to the homeostatic precheckpoint state by eliminat-
ing active signaling proteins. Premature inactivation of the
USP28 branchmight make checkpoint signaling transient,
which is consistent with the block to apoptosis we ob-
served in the absence of USP28. Uncovering the regula-
tion of these E3s will be important in understanding the
underlying rationale of this regulatory mechanism.
Genomic instability and evasion of apoptosis are two
important hallmarks of tumorigenesis (Hanahan andWein-
berg, 2000). Thus, factors that maintain genomic stability
and activate apoptosis are prime targets for mutation
and deregulation during tumorigenesis. For example,
50% of human tumors carry mutations in the TP53 gene
(Vogelstein et al., 2000). Chk2 is mutated in multiple types
of cancer and is responsible for some forms of the cancer
predispositional Li Fraumeni syndrome (Bartek and Lukas,
2003). As USP28 is intimately involved in the Chk2-p53
pathway, it is a likely tumor suppressor candidate.
USP28 maps to 11q23, a region frequently deleted in tu-
mors. Several additional tumor suppressors exist in this
location, including ATM and Chk1, marking this portion
of the genome as a good candidate for a contiguous
gene syndrome involved in tumorigenesis. The discovery
of the critical role for USP28 in the control of critical regu-
lators of DNA-damage signaling opens a new area for in-




USP28 antibodies were generated by immunizing rabbits with a GST-
USP28 fusion protein consisting of GST fused on its C terminus to the
N-terminal 1–332 amino acids of USP28 and affinity purified (Bethyl
Laboratory). Antibodies against phosphoserine 67 and phosphoserine
714 of USP28 were generated by Invitrogen. The 53BP1 antibody used
for immunoprecipitation was provided by Phil Carpenter. Other anti-
bodies used in this study include anti-Mdc1(Ab-1, Stewart, G.), anti-Claspin,
anti-53BP1 and anti-TopBP1 (Bethyl), anti-ATRIP (Cortez, D.), anti-
Nbs1 (Novus Biological), anti-Chk2 (Matsuoka, S.), anti-PUMAa
(Sigma-Aldrich, N-terminal), DO-1 (Oncogene), anti-ATR, anti-b-actin,
Pab1801, FL-393, and C-19 (Santa Cruz). C-terminal TAP-53BP1 was
cloned into pcDNA3.1(). USP28, USP25, and USP7 were cloned us-
ing cDNAmade from H460 cells into phCMV2 (Gene Therapy) to make
HA-USP28, HA-USP25, and HA-USP7. USP28 was mutated using the
QuickChange site-directed mutagenesis kit (Stratagene) to make cat-
alytic inactive USP28 (C171A, USP28CI).
Cell Culture and Cell Extract
ATMwild-type human fibroblast cells (GM00637) and ATM null human
fibroblast cells (GM05849) were cultured in D-MEM supplemented540 Cell 126, 529–542, August 11, 2006 ª2006 Elsevier Inc.with 15% FBS. Lung carcinoma cell lines H460 and H1299 were pro-
vided byW.Gu (Columbia) andwere cultured in D-MEM supplemented
with 10%FBS in an incubator with 7%CO2. HeLa cells stably express-
ing 53BP1-TAP were used for TAP purification. Whole-cell lysates
(WCL) used for immunoprecipitation and for Western blot of different
colon tumor cell lines were made by lysing cells in NETN-150 buffer
(20 mM TrisHCl, pH 8.0; 150 mM NaCl; 1 mM EDTA, 0.5% NP-40)
with or without sonication.
Tandem Affinity Purification
HeLa cells adapted to suspension condition were grown in RPMI-1640
supplemented with 10% FBS in spinner culture flasks. Cell pellets
were lysed in NETN-150 buffer supplemented with protease inhibitors
and phosphatase inhibitors (1 mM NaF and 1 mM NaVO3). Two hun-
dred milligrams of whole-cell lysate was used for the tandem affinity
purification (TAP) purification as described with some modifications
(Rigaut et al., 1999). For each ml of final elute, 5 ml 40 mg/ml sodium
deoxycolate was added and incubated on ice for 30min. Four hundred
and thirty microliters of cold trichloroacetic acid (TCA) was added to
a final concentration of 6% and incubated on ice for 1 hr. Proteins
were pelleted by spinning in a swing-bucket centrifuge (SIGMA
4K15C) at 3000 rpm, 4C for 30 min. Supernatant was removed and
pellets were resuspended in 1 ml cold acetone (stored at20C). After
spinning at 3000 rpm, 4C for 30 min, the pellet was air-dried for 5 min.
The pellet was resuspended in 25 ml of 23 sample buffer and run on
a 4%–20% SDS-PAGE.
siRNA Transfection
All siRNAs were purchased from DHARMACON. The sequence of two
control siRNAs are as follows: GFP, GGCUACGUCCAGGAGC
GCACC); Non-specific Control VIII, ACUCUAUCUGCACGCUGAC;
USP28, 1: CUGCAUUCACCUUAUCAUU and 2: UUGGUUUAGU
GCUGUUAUU); USP25, ACAAGUUCCUUAUCGAUUA; and Chk2,
GAACCUGAGGACCAAGAAC (Ahn et al., 2003). All siRNA transfec-
tions were done with Oligofectamine (Invitrogen). 9 3 104 H460 cells
per well in a 6-well plate were transfected twice with 200 nM siRNA.
One day after the second transfection, cells were trypsinized, pooled
and replated on 6 cm plates.
Apoptosis Assay
For colony-forming assays, H460 cells were transfected twice with
siRNA, treated with different dosage of ionizing irradiation, and re-
seeded at low density. Cells were incubated for 10 days to allow col-
onies to form. Colonies were stained with 2% methylene blue/50%
ethanol and counted. For the sub-G1 DNA content assay, cells were
collected and stained with propidium iodide. Sub-G1 cells were ana-
lyzed by flow cytometry.
Isolation of Mouse B cells
Single-cell suspensions were prepared from thymus and spleen of 6-
week-old C57/b6 or Chk2/ mice. Erythrocytes were removed with
red blood cell lysing buffer (Sigma). In addition, B cells were depleted
from the thymus using B220 magnetic beads, and T cells were re-
moved from the spleen using a mixture of CD4/CD8 magntic beads
(Dynal). Cells (5 3 106) were then cultured in RPMI with 10% FCS
and b-mercaptoethanol. After treatment 10 Gy or sham irradiation cells
were harvested after 0, 0.5, 1, 2, 4, and 6 hr.
Detection of Endogeneous Polyubiquitinated Proteins
and In Vitro Deubiquitination Assay
Cells were either mock-treated or treated with 20 mM of ALLN for 4 hr.
Cell pellets were then lysed in NETN-150 buffer. Equal amount of pro-
teins were used for immunoprecipitation and blotted with anti-polyubi-
quitin antibody from BIOMOL (Clone FK2). In vitro DUB assay was
done in DUB buffer (10 mM Tris pH 8, 75 mM NaCl, 0.5 mM EDTA,
0.25%NP-40, 5mMDTT, 5 mMMgCl2, and 20mMATP) at 37
C. After
the reaction, an equal volume of 23 SDS-PAGE sample buffer was
added to inactivate the reaction. Proteins were resolved on a 4%–20%
SDS-PAGE and blotted with anti-ubiquitin antibody from Santa Cruz
(FL-76). FLAG-tagged USP28-WT or USP28-CI were transiently ex-
pressed in 293T cells and purified with ANTI-FLAG M2 affinity gel
from SIGMA.
Supplemental Data
Supplemental Data include four figures and can be found with this
article online at http://www.cell.com/cgi/content/full/126/3/529/DC1/.
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